Senju, Bausch settle eye drop litigation against Indian generics maker

09-01-2020

Rory O'Neill

Senju, Bausch settle eye drop litigation against Indian generics maker

Pavel Kapysh / Shutterstock.com

Senju Pharmaceutical and Bausch Health have reached an “amicable settlement” to its patent suit against Aurobindo over generic Prolensa (bromfenac) eye drops, court filings confirm.


Senju, Bausch Health, Prolensa, bromfenac, Aurobindo, Zymaxid, eye drops, ANDA

More on this story

Bausch Health resolves IBS patent litigation
07-05-2020

LSIPR